China’s Strongest Pharmas Likely To Thrive Through Innovation And Acquisition Despite Global Crisis
This article was originally published in The Pink Sheet Daily
Executive Summary
Analysts predict the country’s top 100 pharmas will collectively post a rise in operating profit of more than 20 percent in 2009.